Latest News Archive
Please select Category, Year, and then Month to display items
31 July 2020
|
Story Lacea Loader
As a public higher-education institution in South Africa with a responsibility to contribute to public discourse, the University of the Free State (UFS) will be presenting the 3rd UFS Thought-Leader Series in collaboration with Vrye Weekblad as part of the Vrystaat Literature Festival’s online initiative, VrySpraak-digitaal.
This year, higher-education institutions
globally are placed in the challenging context of COVID-19. Aware and grounded in the reality that the world will not return to the normality of pre-COVID-19, our responsibility as scholars still remains to contribute to public discourse and to offer
innovative solutions that will impact the lives of people nationally and globally in order to help them understand and adapt to a new world order.
Against this background and context, this year’s debates focus on ‘Post-COVID-19, Post-Crisis’,
with Health and Modelling, Politics, Economy, and Predictions for 2021 as the sub-themes. Placed in a COVID-19 context, and in lieu of the Vrystaat Arts Festival,
the series will be presented virtually in the form of one webinar per month during the period August 2020 to November 2020.
Date: 13 August 2020
Topic: Health
and Modelling
Time: 11:30-13:00
RSVP: Alicia Pienaar, pienaaran1@ufs.ac.za
Facilitator:
Max du Preez
Editor: Vrye Weekblad
Biography
Introduction and welcome:
Prof Francis Petersen
Rector and Vice-Chancellor, UFS
Panellists:
Prof Salim Abdool Karim
Director: Centre for the AIDS Programme of Research in South Africa (CAPRISA)
Chair: South African Ministerial Advisory Committee on COVID-19
Biography
Prof Glenda Gray
President and CEO: South African Medical Research Council (SAMRC)
Biography
Prof Felicity Burt
NRF-DST South African Research Chair in vector-borne and zoonotic pathogens research
Biography
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”